JNJ Trading Analysis - 10/23/2026 02:30 PM โ€” TRU-SENTIMENT

JNJ (Johnson & Johnson) at $267.64. True Sentiment Bullish, delta 40-60 call 66% / put 34%, call $671,940 vs put $354,500. RSI 61.6.

TRU-SENTIMENT ยท DeltaNeutral

JNJ Trading Analysis - 10/23/2026 02:30 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

JNJ (Johnson & Johnson) at $267.64. True Sentiment Bullish, delta 40-60 call 66% / put 34%, call $671,940 vs put $354,500. RSI 61.6.

Symbol
JNJ
Price
$267.64
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-10-23 14:30:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Source: tru-sentiment options filter (Delta 40-60 only). Sentiment: Bullish

Call Dollar Volume: $671,940 (65.5%) Put Dollar Volume: $354,500 (34.5%) Total: $1,026,440

Contracts: 626 call / 335 put; Trades: 24 call / 18 put. Pure directional conviction skews bullish (2:1 call dollar ratio).

Note: Options flow shows bullish delta-40-60 positioning, but technical MACD histogram is negative (-0.33), creating divergence per spread recommendation logic.

Key Statistics: JNJ

$268.63 +0.00%
52-Week Range
$184.66 - $281.07
Market Cap
$647.37B
P/E (TTM)
38.90
PEG Ratio
N/A
Beta
0.07
Next Earnings
N/A
Avg Volume
$4.63M
Dividend Yield
0.02%

Fundamental Snapshot

Valuation

P/E (trailing)38.90
EPS (trailing 12 mo)$6.68
Market cap$647.37B
Shares outstanding2,409.9M

Dividend

Dividend yield2.07%
Annual dividend$5.36
Ex-dividend date2026-11-24

Risk & range

Beta0.07
52-week low$184.66
52-week high$281.07
Historical volatility24.1%

Ownership & trading

Institutional ownership50.1%
Average daily volume7.6M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

Recent general-knowledge headlines and context for Johnson & Johnson (JNJ) that may relate to the provided data:

  • JNJ declared a quarterly dividend of $5.36 annualized with ex-dividend date of 2026-11-24, supporting income-focused demand.
  • Company continues litigation progress on talc-related settlements, reducing overhang concerns into late 2026.
  • Pharmaceutical pipeline updates on oncology and immunology treatments highlighted in recent investor communications.
  • Medical device segment showing steady elective-procedure recovery post-seasonality.
  • Broad defensive rotation may benefit low-beta names like JNJ (beta 0.07) amid macro uncertainty.

Context: The ex-dividend event and defensive positioning contrast with the embedded data showing a sharp intraday rally on 2026-10-22 and bullish options flow, suggesting news context aligns with stabilizing sentiment rather than driving volatility.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

  • Trailing P/E: 38.90; Trailing EPS: $6.68; Market Cap: $647.37B; Shares Outstanding: 2.41B.
  • Dividend Yield: 2.07%; Dividend Rate: $5.36; Ex-Dividend: 2026-11-24.
  • Beta: 0.07 (very low market sensitivity); 52-Week Range: $184.66 - $281.07.
  • Institutional Ownership: 50.11%; Average Volume: 7.65M.
  • Historical Volatility: 24.06%; Fiscal Year End: 2025-12-01.
  • PEG Ratio, Forward P/E, P/B, Revenue Growth, Margins, ROE, D/E, FCF: Not available (null).
  • Analyst Consensus / Target Price: Not available (null).

Strengths: Low beta and consistent dividend. Concerns: Elevated trailing P/E of 38.90 with no PEG for validation; lack of margin and cash-flow data limits depth. Fundamentals (defensive, income) diverge from the technically sharp 2026-10-22 move (close $268.63, +4.5% from prior $257.21) and bullish options flow, indicating price action is not fundamentally driven per embedded data.

Current Market Position

Current price per indicators: $268.63 (2026-10-22 close). Recent daily action: 2026-10-21 close $257.21, 2026-10-22 open $260.54, high $269.67, low $259.04, close $268.63, volume 5.42M (above 20d avg 4.66M).

Minute bars (2026-10-21 09:30 to 2026-10-22 15:55): Opened 2026-10-21 at $257.50, drifted to $256.23 by 09:50, then rallied to final bar 2026-10-22 15:55 at $267.64 (last close in minute data) with spike volume 611,877. Intraday momentum: Strong upward push on 2026-10-22, closing near highs before minor pullback.

Resistance (Daily High)
$269.67
Support (Prior Day Close)
$257.21
Support (20d SMA)
$259.42
Resistance (Bollinger Upper)
$272.13

Technical Analysis

Technical Indicators

Current Price
$268.63
SMA 5
$258.85
SMA 20
$259.42
SMA 50
$265.20
RSI (14)
61.60
MACD
-1.63
Signal
-1.31
Histogram
-0.33
BB Middle
$259.42
BB Upper
$272.13
BB Lower
$246.71
ATR 14
$6.79
30d High
$275.23
30d Low
$245.17

SMA alignment: Price ($268.63) > SMA 50 ($265.20) > SMA 20 ($259.42) ~ SMA 5 ($258.85). No golden/death cross; price recovered above all SMAs post 2026-10-13 dip to $249.25.

RSI 61.60: Moderate bullish momentum, not overbought (<70). MACD: -1.63 below signal -1.31, histogram -0.33 (bearish crossover, mild downside bias). Bollinger: Price near upper band ($272.13), expansion vs middle $259.42. 30d range: Price at $268.63 is 78.3% up the range (low $245.17, high $275.23).

True Sentiment Analysis (Delta 40-60 Options)

Source: tru-sentiment options filter (Delta 40-60 only). Sentiment: Bullish

Call Dollar Volume: $671,940 (65.5%) Put Dollar Volume: $354,500 (34.5%) Total: $1,026,440

Contracts: 626 call / 335 put; Trades: 24 call / 18 put. Pure directional conviction skews bullish (2:1 call dollar ratio).

Note: Options flow shows bullish delta-40-60 positioning, but technical MACD histogram is negative (-0.33), creating divergence per spread recommendation logic.

Key Price Levels (Observational Only)

Support (SMA 50)
$265.20
Support (30d Low)
$245.17
Resistance (BB Upper)
$272.13
Resistance (30d High)
$275.23
Neutral Zone (Current)
$268.63

Interactive charts load with JavaScript. This text is the crawlable summary.